(GSK) and Medicines for Malaria Venture (MMV) announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy... ...http://www.pressreleasepoint.com/gsk-and-mmv-announce-fda-breakthrough-therapy-designation-tafenoquine-plasmodium-vivax-malaria
—The governing body of the Programme Coordinating Board—has concluded its three-day meeting in Geneva. The Board called on UNAIDS to support... ...http://www.pressreleasepoint.com/unaids-board-calls-unaids-support-countries-setting-revised-national-targets-antiretroviral-treatmen
African Press Organization GENEVA, Switzerland, December 20, 2013/African Press Organization (APO)/ -- Several tens of thousands of displaced... ...http://www.bizwireexpress.com/showstoryAPO.php?storyid=5705
Glaxo's Malaria Drug Gets US Breakthrough Therapy Designation Intraday Stock Chart LONDON--GlaxoSmithKline PLC (GSK.LN) Friday said the U.S.... ...http://in.advfn.com/news_Glaxos-Malaria-Drug-Gets-US-Breakthrough-Therapy-Designation_60464561.html
The extension will enable the program to receive up to an additional US$ 75 million in funds for technical assistance to strengthen country... ...http://www.bizwireexpress.com/showstoryPRWeb.php?storyid=112395
school assembly programs, Finding the...